LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

Home・Akciju saraksts・Twist Bioscience Corp

Twist Bioscience Corp

Slēgts

SektorsVeselības aprūpe

59.46 -1.67

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

57.47

Max

60.49

Galvenie mērījumi
By Trading Economics
Ienākumi	-14M -44M
Pārdošana	7M 111M
EPS	-0.597
Peļņas marža	-39.761
Darbinieki	979
EBITDA	-16M -40M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+12.88% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 3. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	843M 3.4B
Iepriekšējā atvēršanas cena	61.13
Iepriekšējā slēgšanas cena	59.46

Ziņu noskaņojums

By Acuity

17%

83%

37 / 347 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

31.56 / 38.6884 Atbalsts un pretestība

Twist Bioscience Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 5. maijs 23:43 UTC

Galvenie ziņu notikumi

New Zealand's Unemployment Rate Falls in 1Q

2026. g. 5. maijs 23:20 UTC

Karstas akcijas

Stocks to Watch: AMD, Super Micro, Arista Networks, Freshworks

2026. g. 5. maijs 21:48 UTC

Peļņas

Suncor Energy Reports Higher 1Q Profit on Increased Oil Production

2026. g. 5. maijs 21:05 UTC

Iegādes, apvienošanās, pārņemšana

Canada Antitrust Watchdog Seeks to Kibosh Keyera Deal for Plains' Canada Gas Business -- 4th Update

2026. g. 6. maijs 00:00 UTC

Tirgus saruna

Canada Energy Minister Signals Energy Investments in the Pipeline -- Market Talk

2026. g. 5. maijs 23:39 UTC

Tirgus saruna

Gold Rises; Trump Pauses 'Project Freedom' to See if Iran Deal Can Be Finalized -- Market Talk

2026. g. 5. maijs 22:26 UTC

Tirgus saruna

AMD Data-Center Business Continues to Surge -- Market Talk

2026. g. 5. maijs 22:20 UTC

Tirgus saruna

AMD's AI Revolution is Still in Early Innings, Analysts Say -- Market Talk

2026. g. 5. maijs 22:08 UTC

Peļņas

Correction to "Palantir Beats Forecasts" on May 4. -- WSJ

2026. g. 5. maijs 22:07 UTC

Peļņas

AMD Stock Soars on Strong Earnings and Growing Confidence About AI -- Barrons.com

2026. g. 5. maijs 21:48 UTC

Peļņas

Pan American Silver 1Q Adj EPS $1.09 >PAAS

2026. g. 5. maijs 21:48 UTC

Peļņas

Pan American Silver 1Q Rev $1.2B >PAAS

2026. g. 5. maijs 21:42 UTC

Peļņas

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

2026. g. 5. maijs 21:38 UTC

Peļņas

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

2026. g. 5. maijs 21:30 UTC

Peļņas

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

2026. g. 5. maijs 21:29 UTC

Peļņas

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

2026. g. 5. maijs 21:26 UTC

Peļņas

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Falls. -- Barrons.com

2026. g. 5. maijs 21:25 UTC

Peļņas

Alcon Inc. 1Q EPS 39c >ALC.EB

2026. g. 5. maijs 21:25 UTC

Peļņas

Alcon Inc. 1Q Rev $2.71B >ALC.EB

2026. g. 5. maijs 21:24 UTC

Peļņas

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

2026. g. 5. maijs 21:18 UTC

Peļņas

Mistras Backs 2026 Rev $730M-$750M >MG

2026. g. 5. maijs 21:17 UTC

Peļņas

AMD Stock Jumps on Solid Earnings. AI Continues to Drive Data Center Chips. -- Barrons.com

2026. g. 5. maijs 21:15 UTC

Peļņas

Strategy Records Loss of Nearly $13 Billion as Bitcoin Continues Decline -- WSJ

2026. g. 5. maijs 21:12 UTC

Peļņas

These Stocks Are Today's Movers: Intel, PayPal, Palantir, Shopify, Micron, Duolingo, and More -- Barrons.com

2026. g. 5. maijs 21:11 UTC

Peļņas

SSR Mining 1Q Rev $581.8M >SSRM

2026. g. 5. maijs 21:10 UTC

Peļņas

SSR Mining 1Q Adj EPS $1.15 >SSRM

2026. g. 5. maijs 21:10 UTC

Peļņas

SSR Mining 1Q EPS $1.16 >SSRM

2026. g. 5. maijs 21:08 UTC

Peļņas

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

2026. g. 5. maijs 21:01 UTC

Peļņas

Intact Financial 1Q EPS C$4.12 >IFC.T

2026. g. 5. maijs 21:01 UTC

Karstas akcijas

Stocks to Watch Recap: Palantir, AMD, Intel, HSBC -- WSJ

Salīdzinājums

Cenas izmaiņa

Twist Bioscience Corp Prognoze

Cenas mērķis

By TipRanks

12.88% augšup

Prognoze 12 mēnešiem

Vidējais 63.43 USD 12.88%

Augstākais 70 USD

Zemākais 56 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Twist Bioscience Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

7 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 7 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Twist Bioscience Corp — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

31.56 / 38.6884Atbalsts un pretestība

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

Noskaņojums

By Acuity

37 / 347 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.